Spruce Biosciences(SPRB)
SOUTH SAN FRANCISCO, CA
BiotechnologyFocus: Treatments for diseases affecting the hypothalamic-pituitary-adrenal (HPA) axis
Spruce Biosciences is a life sciences company focused on Treatments for diseases affecting the hypothalamic-pituitary-adrenal (HPA) axis.
EndocrinologyNephrology
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
Phase 2
Clinical Trials (1)
NCT03687242Study to Evaluate the Safety and Efficacy of SPR001 in Subjects With Classic Congenital Adrenal Hyperplasia
Phase 2Tildacerfont/Placebo
Congenital Adrenal HyperplasiaClinical Trials (1)
NCT04457336A Ph2b to Evaluate Clinical Efficacy and Safety of Tildacerfont in Adult CAH
Phase 2Tildacerfont/Placebo
Congenital Adrenal HyperplasiaClinical Trials (1)
NCT04544410A Ph2b to Evaluate Tildacerfont in the Reduction of Glucocorticoid Steroid Doses in Adult CAH
Phase 2Tildacerfont
Polycystic Ovary SyndromeClinical Trials (1)
NCT05370521A Study of Safety and Efficacy of Tildacerfont in Females With Polycystic Ovary Syndrome and Elevated Adrenal Androgens
Phase 2Tildacerfont
Congenital Adrenal HyperplasiaClinical Trials (1)
NCT05128942A Phase 2 Study to Evaluate the Safety, Efficacy and PK of Tildacerfont in Children Aged 2-17 Years With CAH
Phase 2Phase 2
Clinical Trials (1)
NCT03257462Study of SPR001 in Adults With Classic Congenital Adrenal Hyperplasia
Phase 2Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2017
Portfolio: 6 clinical trials
SEC Filings: 2 available